These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

251 related items for PubMed ID: 4030546

  • 1. Comparative in-vitro activity of Sch 34343 for a wide spectrum of clinically significant anaerobic bacteria.
    Wells CL, Wilkins TD.
    J Antimicrob Chemother; 1985 Jun; 15 Suppl C():177-82. PubMed ID: 4030546
    [Abstract] [Full Text] [Related]

  • 2. Susceptibility of anaerobic bacteria to Sch 34343 and other antibiotics.
    Glupczynski Y, Gordts B, van der Linden MP, Labbé M, Yourassowsky E, Butzler JP.
    J Antimicrob Chemother; 1985 Jun; 15 Suppl C():193-8. PubMed ID: 4030548
    [Abstract] [Full Text] [Related]

  • 3. Comparative in-vitro activity of Sch 34343 and other antimicrobial agents against anaerobic bacteria.
    Nord CE, Olsson-Liljequist B.
    J Antimicrob Chemother; 1985 Jun; 15 Suppl C():183-8. PubMed ID: 2863246
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Activity of WY-49605 compared with those of amoxicillin, amoxicillin-clavulanate, imipenem, ciprofloxacin, cefaclor, cefpodoxime, cefuroxime, clindamycin, and metronidazole against 384 anaerobic bacteria.
    Spangler SK, Jacobs MR, Appelbaum PC.
    Antimicrob Agents Chemother; 1994 Nov; 38(11):2599-604. PubMed ID: 7872754
    [Abstract] [Full Text] [Related]

  • 7. Antimicrobial susceptibility of anaerobic bacteria in Sweden in 1983.
    Nord CE, Olsson-Liljequist B.
    Scand J Infect Dis Suppl; 1984 Nov; 43():44-9. PubMed ID: 6100139
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. [Antimicrobial activity of ornidazole and 6 other antibiotics against anaerobic bacteria].
    Alados JC, Martínez-Brocal A, Miranda C, Rojo MD, García V, Domínguez MC, de la Rosa M.
    Enferm Infecc Microbiol Clin; 1991 Apr; 9(4):219-22. PubMed ID: 1863621
    [Abstract] [Full Text] [Related]

  • 11. Susceptibility of anaerobic bacteria to antimicrobial agents.
    Collignon PJ, Munro R, Morris G.
    Pathology; 1988 Jan; 20(1):48-52. PubMed ID: 3374973
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. BMY28142, cefbuperazone (T-1982), and Sch 34343. Antimicrobial activity against 94 anaerobes compared to seven other antimicrobial agents.
    Jones RN, Barry AL, Packer RR.
    Diagn Microbiol Infect Dis; 1985 May; 3(3):263-8. PubMed ID: 3838925
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. In vitro activity of Sch 34343 and cefbuperazone against anaerobic bacteria.
    Shafran SD, Wong J, Chow AW.
    Antimicrob Agents Chemother; 1985 May; 27(5):749-52. PubMed ID: 4015069
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. In vitro activity of cefoperazone plus sulbactam compared with that of other antimicrobial agents against anaerobic bacteria.
    Wexler HM, Finegold SM.
    Antimicrob Agents Chemother; 1988 Mar; 32(3):403-6. PubMed ID: 3364960
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Evaluation of the in vitro activity of levornidazole, its metabolites and comparators against clinical anaerobic bacteria.
    Hu J, Zhang J, Wu S, Zhu D, Huang H, Chen Y, Yang Y, Zhang Y.
    Int J Antimicrob Agents; 2014 Dec; 44(6):514-9. PubMed ID: 25301712
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.